Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

NexgenRx Inc

NXG.V ✗ NOT COMPLIANT ☆ Track — members

TSX Venture · Financials · Investment Management & Fund Operators ·

Canada Micro Cap Analyst: N/A

Last Close

$0.43

▲ +7.14%

Market Cap $30.63M · Vol 24.01K

Key Metrics

P/E Ratio

27.40

FWD: N/A

Market Cap

$30.63M

Micro Cap

Div Yield

1.79%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

25.00

Momentum

Beta

0.47

vs Market

52W High

$0.54

18.86% below

52W Low

$0.21

104.32% above

Volume

24.01K

Avg 14.55K

P/B

4.76

Price-to-book

ROE

N/A

Return on equity

Free Float

63.01%

Public shares

Shariah Compliance8 STANDARDS

✗ NexgenRx Inc (NXG.V) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NXG.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+15.38%

+76.47%

+71.43%

YTD

+50.00%

+62.16%

N/A

+73.91%

Financials & Valuation

TTM · Annual

Total Revenue	$13.07M
Net Income	$939.77K
Revenue Growth (YoY)	+9.82%
Gross Margin	76.46%
Operating Margin	12.45%
Net Profit Margin	7.19%
ROE	N/A
ROA · ROIC	5.77% · 16.20%

P/E Ratio	27.40
Forward P/E (FY1)	N/A
PEG Ratio	0.50
P/S	1.72
P/B	4.76
P/FCF	6.66
EPS Growth	N/A
Outstanding Shares	71.12M

Technical Indicators

50-Day SMA	$0.38
200-Day SMA	$0.30
RSI (14)	25.00
Beta	0.47
52-Week High	$0.54
52-Week Low	$0.21

Volume Today	24.01K
Avg Daily Volume (30D)	14.55K
Relative Volume	1.65x
Volatility (10D)	67.86
Volatility (30D)	77.28
Free Float	63.01%

Analyst Consensus

N/A

Current Price $0.43

Mean Target N/A

52W Low$0.21 52W High$0.54

Current

Target

$0.21 $0.54

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001SK9V59

ISINCA65337X1042

CountryCanada

Sub-IndustryInvestment Management & Fund Operators (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

DRR.AX Deterra Royalties Ltd -2.31% 4084.SE Derayah Financial Company SJSC +0.05% DBIH.OM Al Batinah Development and Investment Holding Co SAOG +0.00% ROKO B.ST Roko AB (publ) +1.67% ALSAFAT.KW Al Safat Investment Company KSCP -1.54%

Company Profile

NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. It offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.